{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T11:48:30Z","timestamp":1789213710355,"version":"build-2803163510"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19K08832"],"award-info":[{"award-number":["19K08832"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.exphem.2022.09.005","type":"journal-article","created":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T23:38:38Z","timestamp":1664581118000},"page":"37-49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Establishment and characterization of a new activated B-cell-like DLBCL cell line, TMD12"],"prefix":"10.1016","volume":"116","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1766-3842","authenticated-orcid":false,"given":"Toshikage","family":"Nagao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kota","family":"Yoshifuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daichi","family":"Sadato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1315-4936","authenticated-orcid":false,"given":"Yotaro","family":"Motomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makiko","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurara","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouhei","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Nogami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2022.09.005_bib0001","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2022.09.005_bib0002","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa012914","article-title":"The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma","volume":"346","author":"Rosenwald","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2022.09.005_bib0003","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nature08638","article-title":"Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma","volume":"463","author":"Davis","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2022.09.005_bib0004","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nature09671","article-title":"Oncogenically active MYD88 mutations in human lymphoma","volume":"470","author":"Ngo","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2022.09.005_bib0005","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1038\/nm.3884","article-title":"Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma","volume":"21","author":"Wilson","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.exphem.2022.09.005_bib0006","doi-asserted-by":"crossref","first-page":"E7260","DOI":"10.1073\/pnas.1610970113","article-title":"Epigenetic gene regulation by Janus kinase 1 in diffuse large B-cell lymphoma","volume":"113","author":"Rui","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2022.09.005_bib0007","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1182\/blood-2007-04-087734","article-title":"Constitutively activated STAT3 promotes cell proliferation and survival in the activated B-cell subtype of diffuse large B-cell lymphomas","volume":"111","author":"Ding","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2022.09.005_bib0008","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1182\/bloodadvances.2021006147","article-title":"A new role for the SRC family kinase HCK as a driver of SYK activation in MYD88 mutated lymphomas","volume":"6","author":"Munshi","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.exphem.2022.09.005_bib0009","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1158\/0008-5472.CAN-10-2380","article-title":"STAT3 inhibition is a therapeutic strategy for ABC-like diffuse large B-cell lymphoma","volume":"71","author":"Scuto","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2022.09.005_bib0010","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.1158\/1078-0432.CCR-14-0683","article-title":"Clinical implications of phosphorylated STAT3 expression in de novo diffuse large B-cell lymphoma","volume":"20","author":"Ok","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.exphem.2022.09.005_bib0011","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41586-018-0290-0","article-title":"A multiprotein supercomplex controlling oncogenic signalling in lymphoma","volume":"560","author":"Phelan","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2022.09.005_bib0012","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ccell.2020.03.015","article-title":"A probabilistic classification tool for genetic subtypes of diffuse large B cell lymphoma with therapeutic implications","volume":"37","author":"Wright","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2022.09.005_bib0013","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.leukres.2006.05.003","article-title":"Establishment of a novel B-cell lymphoma cell line with suppressed growth by gamma-secretase inhibitors","volume":"30","author":"Tohda","year":"2006","journal-title":"Leuk Res"},{"key":"10.1016\/j.exphem.2022.09.005_bib0014","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1182\/blood-2006-07-025809","article-title":"Aberrant NF-kB signaling in lymphoma: mechanisms, consequences, and therapeutic implications","volume":"109","author":"Jost","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2022.09.005_bib0015","doi-asserted-by":"crossref","first-page":"5655","DOI":"10.1038\/onc.2013.565","article-title":"Mechanisms and consequences of constitutive NF-kB activation in B-cell lymphoid malignancies","volume":"33","author":"Nagel","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2022.09.005_bib0016","first-page":"4088","article-title":"Structure and transforming potential of the human cot oncogene encoding a putative protein kinase","volume":"11","author":"Miyoshi","year":"1991","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.exphem.2022.09.005_bib0017","doi-asserted-by":"crossref","first-page":"8343","DOI":"10.7150\/thno.45848","article-title":"Tumor progression locus 2 (TPL2) in tumor-promoting inflammation, tumorigenesis and tumor immunity","volume":"10","author":"Njunge","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.exphem.2022.09.005_bib0018","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.phrs.2017.11.031","article-title":"TPL2 kinase action and control of inflammation","volume":"129","author":"Xu","year":"2018","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.exphem.2022.09.005_bib0019","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1600-065X.2012.01104.x","article-title":"IkB kinase regulation of the TPL-2\/ERK MAPK pathway","volume":"246","author":"Gantke","year":"2012","journal-title":"Immunol Rev"},{"key":"10.1016\/j.exphem.2022.09.005_bib0020","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3390\/cells7090133","article-title":"NFKB1 and cancer: friend or foe?","volume":"7","author":"Concetti","year":"2018","journal-title":"Cells"},{"key":"10.1016\/j.exphem.2022.09.005_bib0021","doi-asserted-by":"crossref","first-page":"4471","DOI":"10.3390\/ijms16034471","article-title":"Tumor progression locus 2 (Tpl2) kinase as a novel therapeutic target for cancer: double-sided effects of Tpl2 on cancer","volume":"16","author":"Lee","year":"2015","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.exphem.2022.09.005_bib0022","doi-asserted-by":"crossref","first-page":"5063","DOI":"10.1182\/blood-2007-10-120832","article-title":"NF-kB1 and c-Rel cooperate to promote the survival of TLR4-activated B cells by neutralizing Bim via distinct mechanisms","volume":"112","author":"Banerjee","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2022.09.005_bib0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-14502-x","article-title":"A central role of IKK2 and TPL2 in JNK activation and viral B-cell transformation","volume":"11","author":"Voigt","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.exphem.2022.09.005_bib0024","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0255257","article-title":"Archival bone marrow smears are useful in targeted next-generation sequencing for diagnosing myeloid neoplasms","volume":"16","author":"Sadato","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.exphem.2022.09.005_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1004873","article-title":"CNVkit: genome-wide copy number detection and visualization from targeted DNA sequencing","volume":"12","author":"Talevich","year":"2016","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.exphem.2022.09.005_bib0026","doi-asserted-by":"crossref","first-page":"9189","DOI":"10.18632\/oncotarget.3279","article-title":"FLT3-ITD confers resistance to the PI3K\/Akt pathway inhibitors by protecting the mTOR\/4EBP1\/Mcl-1 pathway through STAT5 activation in acute myeloid leukemia","volume":"6","author":"Nogami","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.exphem.2022.09.005_bib0027","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2022.09.005_bib0028","doi-asserted-by":"crossref","DOI":"10.1093\/narcan\/zcab001","article-title":"Systematic identification of non-coding somatic single nucleotide variants associated with altered transcription and DNA methylation in adult and pediatric cancers","volume":"3","author":"Chen","year":"2021","journal-title":"NAR Cancer"},{"key":"10.1016\/j.exphem.2022.09.005_bib0029","doi-asserted-by":"crossref","DOI":"10.1177\/20406207211072839","article-title":"MYD88L265P and CD79B double mutations type (MCD type) of diffuse large B-cell lymphoma: mechanism, clinical characteristics, and targeted therapy","volume":"13","author":"Chen","year":"2022","journal-title":"Ther Adv Hematol"},{"key":"10.1016\/j.exphem.2022.09.005_bib0030","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1084\/jem.20091167","article-title":"Inhibition of MALT1 protease activity is selectively toxic for activated B cell-like diffuse large B cell lymphoma cells","volume":"206","author":"Ferch","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2022.09.005_bib0031","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nature07968","article-title":"Mutations of multiple genes cause deregulation of NF-kB in diffuse large B-cell lymphoma","volume":"459","author":"Compagno","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2022.09.005_bib0032","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/leu.2016.243","article-title":"Loss of PRDM1\/BLIMP-1 function contributes to poor prognosis of activated B-cell-like diffuse large B-cell lymphoma","volume":"31","author":"Xia","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2022.09.005_bib0033","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-10684-5","article-title":"Interleukin-6-dependent growth in a newly established plasmablastic lymphoma cell line and its therapeutic targets","volume":"7","author":"Mine","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.exphem.2022.09.005_bib0034","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1182\/blood-2017-11-764332","article-title":"Genetics of diffuse large B-cell lymphoma","volume":"131","author":"Pasqualucci","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2022.09.005_bib0035","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.591577","article-title":"Genetic and non-genetic mechanisms of resistance to BCR signaling inhibitors in B cell malignancies","volume":"10","author":"Ondrisova","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.exphem.2022.09.005_bib0036","doi-asserted-by":"crossref","first-page":"16981","DOI":"10.1073\/pnas.1905239116","article-title":"Repurposing dasatinib for diffuse large B cell lymphoma","volume":"116","author":"Scuoppo","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2022.09.005_bib0037","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171221","article-title":"PI3K\u03b4 inhibitor idelalisib in combination with BTK inhibitor ONO\/GS-4059 in diffuse large B cell lymphoma with acquired resistance to PI3K\u03b4 and BTK inhibitors","volume":"12","author":"Yahiaoui","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.exphem.2022.09.005_bib0038","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/bjh.12172","article-title":"Lenalidomide efficacy in activated B-cell-like subtype diffuse large B-cell lymphoma is dependent upon IRF4 and cereblon expression","volume":"160","author":"Zhang","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2022.09.005_bib0039","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1128\/MCB.00564-12","article-title":"Coordinate regulation of TPL-2 and NF-kB signaling in macrophages by NF-kB1 p105","volume":"32","author":"Yang","year":"2012","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.exphem.2022.09.005_bib0040","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/bjh.12175","article-title":"MAP3K8 kinase regulates myeloma growth by cell-autonomous and non-autonomous mechanisms involving myeloma-associated monocytes\/macrophages","volume":"160","author":"Hebron","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2022.09.005_bib0041","doi-asserted-by":"crossref","first-page":"4224","DOI":"10.1038\/onc.2017.90","article-title":"Molecular impact of selective NFKB1 and NFKB2 signaling on DLBCL phenotype","volume":"36","author":"Guo","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2022.09.005_bib0042","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/ejh.12117","article-title":"Cell cycle regulation score predicts relapse-free survival in non-germinal centre diffuse large B-cell lymphoma patients treated by means of immunochemotherapy","volume":"91","author":"Pasanen","year":"2013","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.exphem.2022.09.005_bib0043","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.ccell.2021.10.006","article-title":"Effect of ibrutinib with R-CHOP chemotherapy in genetic subtypes of DLBCL","volume":"39","author":"Wilson","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2022.09.005_bib0044","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1182\/blood-2008-12-194852","article-title":"TNFAIP3\/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas","volume":"114","author":"Honma","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2022.09.005_bib0045","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/nature07969","article-title":"Frequent inactivation of A20 in B-cell lymphomas","volume":"459","author":"Kato","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2022.09.005_bib0046","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1080\/10428190701817282","article-title":"Characterization of 6q deletions in mature B cell lymphomas and childhood acute lymphoblastic leukemia","volume":"49","author":"Thelander","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.exphem.2022.09.005_bib0047","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bcp.2009.02.009","article-title":"ABINs: A20 binding inhibitors of NF-kB and apoptosis signaling","volume":"78","author":"Verstrepen","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.exphem.2022.09.005_bib0048","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3109\/10428194.2011.621566","article-title":"Interleukin-6 plasma levels are modulated by a polymorphism in the NF-kB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma","volume":"53","author":"Giachelia","year":"2012","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.exphem.2022.09.005_bib0049","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1158\/1078-0432.CCR-10-1859","article-title":"A20, ABIN-1\/2, and CARD11 mutations and their prognostic value in gastrointestinal diffuse large B-cell lymphoma","volume":"17","author":"Dong","year":"2011","journal-title":"Clin Cancer Res"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X22007007?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X22007007?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:37:41Z","timestamp":1759567061000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X22007007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":49,"alternative-id":["S0301472X22007007"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2022.09.005","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Establishment and characterization of a new activated B-cell-like DLBCL cell line, TMD12","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2022.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 ISEH -- Society for Hematology and Stem Cells. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}